For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months ...

Opens in a new tab or window ORLANDO -- Vedolizumab (Entyvio) and infliximab (Remicade) led to mostly similar 1-year outcomes ...

Upadacitinib may offer superior disease management than tofacitinib for patients with ulcerative colitis. Learn more.

Teva Pharmaceuticals and Sanofi announced positive results in a Phase 2b trial of their drug for ulcerative colitis and Crohn ...

diff) is a bacterial infection that commonly affects people with ulcerative colitis (UC ... so you may need to change or intensify your treatment plan. People with UC and C.

More than half (62.7%) of respondents reported facing financial barriers to obtaining their IBD medication.

The search for effective therapies in ulcerative colitis, a chronic inflammatory condition affecting the colon and rectum ...

IBD, on the other hand, is an umbrella term used to describe ... led by the Crohn's & Colitis Foundation found nearly 1 in 100 people living in the U.S. have IBD. The two most common forms of IBD are ...

The Institute for Clinical and Economic Review has identified five drugs — Biktarvy, Darzalex, Entresto, Cabometyx, and ...

A new research study conducted in Manitoba has shown that electrical stimulation of the ears has shown promise as a possible treatment for ulcerative colitis.

For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months ...